de Wolf JT - Search Results

1

Pharmaco-economics of blood transfusion safety: review of the available evidence.

van Hulst M, de Wolf JT, Staginnus U, Ruitenberg EJ, Postma MJ. van Hulst M, et al. Among authors: de wolf jt. Vox Sang. 2002 Aug;83(2):146-55. doi: 10.1046/j.1423-0410.2002.00198.x. Vox Sang. 2002. PMID: 12201844 Review.

2

Cost-effectiveness of pathogen inactivation for platelet transfusions in the Netherlands.

Postma MJ, van Hulst M, De Wolf JT, Botteman M, Staginnus U. Postma MJ, et al. Among authors: de wolf jt. Transfus Med. 2005 Oct;15(5):379-87. doi: 10.1111/j.1365-3148.2005.00609.x. Transfus Med. 2005. PMID: 16202052

3

Blood loss in orthotopic liver transplantation: a retrospective analysis of transfusion requirements and the effects of autotransfusion of cell saver blood in 164 consecutive patients.

Hendriks HG, van der Meer J, Klompmaker IJ, Choudhury N, Hagenaars JA, Porte RJ, de Kam PJ, Slooff MJ, de Wolf JT. Hendriks HG, et al. Among authors: de kam pj, de wolf jt. Blood Coagul Fibrinolysis. 2000 Apr;11 Suppl 1:S87-93. doi: 10.1097/00001721-200004001-00017. Blood Coagul Fibrinolysis. 2000. PMID: 10850571

4

Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: a pilot study.

Hendriks HG, Meijer K, de Wolf JT, Klompmaker IJ, Porte RJ, de Kam PJ, Hagenaars AJ, Melsen T, Slooff MJ, van der Meer J. Hendriks HG, et al. Among authors: de kam pj, de wolf jt. Transplantation. 2001 Feb 15;71(3):402-5. doi: 10.1097/00007890-200102150-00011. Transplantation. 2001. PMID: 11233901 Clinical Trial.

5

The application of hematopoietic growth factors in drug-induced agranulocytosis: a review of 70 cases.

Sprikkelman A, de Wolf JT, Vellenga E. Sprikkelman A, et al. Among authors: de wolf jt. Leukemia. 1994 Dec;8(12):2031-6. Leukemia. 1994. PMID: 7528854 Review.

6

Intraoperative blood transfusion requirement is the main determinant of early surgical re-intervention after orthotopic liver transplantation.

Hendriks HG, van der Meer J, de Wolf JT, Peeters PM, Porte RJ, de Jong K, Lip H, Post WJ, Slooff MJ. Hendriks HG, et al. Among authors: de jong k, de wolf jt. Transpl Int. 2005 Jan;17(11):673-9. doi: 10.1007/s00147-004-0793-5. Epub 2004 Dec 10. Transpl Int. 2005. PMID: 15717214

7

Risk of transmission of human immunodeficiency virus (HIV) by heat-treated factor VIII concentrates in patients with severe hemophilia A.

Daenen S, Hoogeveen Y, Smit JW, van Imhoff GW, van der Meer J, de Wolf JT, Sibinga CT, Halie RM. Daenen S, et al. Among authors: de wolf jt. Transfusion. 1987 Nov-Dec;27(6):482-4. doi: 10.1046/j.1537-2995.1987.27688071700.x. Transfusion. 1987. PMID: 3120376

8

Platelet kinetic studies in patients with idiopathic thrombocytopenic purpura.

Louwes H, Zeinali Lathori OA, Vellenga E, de Wolf JT. Louwes H, et al. Among authors: de wolf jt. Am J Med. 1999 Apr;106(4):430-4. doi: 10.1016/s0002-9343(99)00054-6. Am J Med. 1999. PMID: 10225246

9

Severe bleeding caused by an inhibitor to coagulation factor V: a case report.

Smid WM, de Wolf JT, Nijland JH, Bom VJ, van der Meer J. Smid WM, et al. Among authors: de wolf jt. Blood Coagul Fibrinolysis. 1994 Feb;5(1):133-7. doi: 10.1097/00001721-199402000-00015. Blood Coagul Fibrinolysis. 1994. PMID: 8180333

10

Effective treatment of severe bleeding due to acquired thrombocytopathia by single dose administration of activated recombinant factor VII.

Meijer K, Sieders E, Slooff MJ, de Wolf JT, van der Meer J. Meijer K, et al. Among authors: de wolf jt. Thromb Haemost. 1998 Jul;80(1):204-5. Thromb Haemost. 1998. PMID: 9684815 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters